Jake Curhan

Right Guard

Free Agency: 2024 (RFA)
Accrued Seasons: 0
  • 2021 Salary Cap Charge: $669,500 (0.37% of cap)
  • 2021 Cash Payout: $688,500 (0.32% of spending)
  • 2021 Cash to Cap Ratio: 1.03
  • Contract Value: $2,453,500 ($817,833 APY)
  • Fully Guaranteed Money: $28,500
  • Contract Ranking: 55/96 at RG

Current Contract

(UDFA, signed 2021)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusCap
Number
Cap %
Dead Money & Cap Savings
2021$660,000$9,500$669,5000.4%
2022$825,000$9,500$834,5000.4%
2023$940,000$9,500$949,5000.4%
Total$2,425,000$28,500$2,453,500

Cash Flows

- fully earned money
- unearned or partially earned money
$0.8M
$1.6M
$2.5M
202120222023
Cash Due$688,500$825,000$940,000
Running Cash$688,500$1,513,500$2,453,500
Career Earnings: $28,500
Career APY: $0
Potential Earnings: $2,453,500
Total Guarantees: $28,500
Largest Cash Payment: $940,000 (2023)
Largest Cap Number: $949,500 (2023)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
SeahawksUDFAActive20213$2,453,500$817,833$28,500$28,5001.2%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Seahawks0$28,500$0$00.0%$00.0%

Statistics

No statistics available.

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$0$0
Injury Adjusted$0$0
test
OTC Valuation $2.1M $4.3M $6.4M $8.5M $10.6M APY $3.0M $6.0M $9.0M $12.0M $15.0M $6,037,000 $1,879,599

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.